
    
      The recruitment period will be 24 months. The duration of the study will be 6 months for each
      patient due to adjustments of apomorphine pump parameters and oral medication as well time
      needed for motor and nonmotor changes to develop and influence QoL.

      This study will be done without any modification of the planned treatment plan for each
      patient included. The treatments are administered in accordance with their marketing
      authorization and according to the usual practices of each center. No additional visits are
      expected.
    
  